Premium
Diagnosis and management of subcutaneous implantable cardioverter‐defibrillator infections based on process mapping
Author(s) -
Baddour Larry M.,
Weiss Raul,
Mark George E.,
ElChami Mikhael F.,
Biffi Mauro,
Probst Vincent,
Lambiase Pier D.,
Miller Marc A.,
McCler Timothy,
Hansen Linda K.,
Knight Bradley P.
Publication year - 2020
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/pace.13902
Subject(s) - medicine , implantable cardioverter defibrillator , intensive care medicine , medline , medical emergency , political science , law
Background Infection is a well‐recognized complication of cardiovascular implantable electronic device (CIED) implantation, including the more recently available subcutaneous implantable cardioverter‐defibrillator (S‐ICD). Although the AHA/ACC/HRS guidelines include recommendations for S‐ICD use, currently there are no clinical trial data that address the diagnosis and management of S‐ICD infections. Therefore, an expert panel was convened to develop consensus on these topics. Methods A process mapping methodology was used to achieve a primary goal – the development of consensus on the diagnosis and management of S‐ICD infections. Two face‐to‐face meetings of panel experts were conducted to recommend useful information to clinicians in individual patient management of S‐ICD infections. Results Panel consensus of a stepwise approach in the diagnosis and management was developed to provide guidance in individual patient management. Conclusion Achieving expert panel consensus by process mapping methodology in S‐ICD infection diagnosis and management was attainable, and the results should be helpful in individual patient management.